Neos Therapeutics, Inc. Contracts & Agreements

Consent, Waiver and Sixth Amendment to Facility Agreement, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC, Neos Therapeutics, LP, Neos... (Filed With SEC on March 22, 2021)

Consent, Waiver and Amendment No. 1 to Loan and Security Agreement, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC, Neos Therapeutics,... (Filed With SEC on March 22, 2021)

Unsecured Convertible Promissory Note, by and between Neos and Aytu (Filed With SEC on February 8, 2021)

Registration Rights Agreement, by and between Neos and Aytu (Filed With SEC on February 8, 2021)

Subordination Agreement, by and among Neos, Aytu, Deerfield Private Design Fund III, L.P. and Deerfield Partners, L.P (Filed With SEC on February 8, 2021)

Subordination Agreement, by and among Neos, Aytu, Neos Therapeutics Brands, LLC, Neos Therapeutics, LP, Neos Therapeutics Commercial, LLC, Pharmafab Texas, LLC and Encina Business... (Filed With SEC on February 8, 2021)

Agreement and Plan of Merger, dated as of December 10, by and among Neos, Therapeutics, Inc., Aytu BioScience, Inc. and Neutron Acquisition Sub, Inc (Filed With SEC on December 11, 2020)

Form of Parent Stockholder Voting Agreement (Filed With SEC on December 11, 2020)

Form of Company Stockholder Voting Agreement (Filed With SEC on December 11, 2020)

Commitment Letter, dated as of December 10, 2020, by and between Aytu BioScience, Inc. and Neos Therapeutics, Inc (Filed With SEC on December 11, 2020)

Form of Unsecured Convertible Promissory Note, by and between Neos and Aytu (Filed With SEC on December 11, 2020)

Deerfield Consent Letter, dated as of December 10, 2020, by and among Aytu, Neos and the Deerfield Lenders (Filed With SEC on December 11, 2020)

Limited Waiver, dated as of December 10, 2020, by and between Neos and the Deerfield Lenders (Filed With SEC on December 11, 2020)

Commitment Letter, dated as of December 10, 2020, by and between Encina, Encina Business Credit SPV, LLC, Neos and Aytu (Filed With SEC on December 11, 2020)

Limited Waiver to Loan and Security Agreement, dated as of December 10, 2020, by and between Neos, Encina and Encina Business Credit SPV, LLC (Filed With SEC on December 11, 2020)

Limited Waiver, dated as of November 9, 2020, among the Registrant, its subsidiary guarantors, Deerfield Private Design Fund III, L.P. and Deerfield Partners, L.P., as lenders,... (Filed With SEC on November 9, 2020)

Second Amendment to Employment Agreement, by and between the Registrant and Gerald McLaughlin, dated as of April 1, 2020 (Filed With SEC on August 10, 2020)

Third Amendment to Employment Agreement, by and between the Registrant and Gerald McLaughlin, dated as of June 18, 2020 (Filed With SEC on August 10, 2020)

Second Amendment to Amended and Restated Employment Agreement, by and between the Registrant and Richard I. Eisenstadt, dated as of April 1, 2020 (Filed With SEC on August 10, 2020)

Third Amendment to Amended and Restated Employment Agreement, by and between the Registrant and Richard I. Eisenstadt, dated as of June 18, 2020 (Filed With SEC on August 10, 2020)

Second Amendment to Employment Agreement, by and between the Registrant and John M. Limongelli, dated as of April 1, 2020 (Filed With SEC on August 10, 2020)

Third Amendment to Employment Agreement, by and between the Registrant and John M. Limongelli, dated as of June 18, 2020 (Filed With SEC on August 10, 2020)

Neos Therapeutics, Inc. Non-Employee Director Compensation Policy dated June 10, 2020 (Filed With SEC on June 11, 2020)

Employment Agreement dated March 18, 2019, by and between the Registrant and John Limongelli (corrected version of previously-filed exhibit) (Filed With SEC on May 11, 2020)

U.S. Small Business Administration Paycheck Protection Program Note dated April 18, 2020 by and between the Registrant and First Republic Bank (Filed With SEC on May 11, 2020)

Form of Second Amended and Restated Senior Secured Convertible Note (Filed With SEC on May 7, 2020)

Fifth Amendment to Facility Agreement, dated as of May 6, 2020, by and among Neos Therapeutics, Inc., the guarantor parties thereto, Deerfield Private Design Fund III, L.P. and... (Filed With SEC on May 7, 2020)

Description of Capital Stock (Filed With SEC on March 13, 2020)

First Amendment to Employment Agreement, by and between the Registrant and Gerald McLaughlin, dated as of October 1, 2019 (Filed With SEC on March 13, 2020)

First Amendment to Amended and Restated Employment Agreement, by and between the Registrant and Richard Eisenstadt, dated as of October 1, 2019 (Filed With SEC on March 13, 2020)

First Amendment to Amended and Restated Employment Agreement, by and between the Registrant and John Limongelli, dated as of October 1, 2019 (Filed With SEC on March 13, 2020)

Intercreditor Agreement, dated as of October 2, 2019, by and between the Agent, Deerfield Mgmt, L.P., and certain creditors, including Deerfield Private Design Fund III, L.P. and... (Filed With SEC on October 3, 2019)

Loan and Security Agreement, dated as of October 2, 2019, by and between Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC and Neos Therapeutics, LP, as borrowers, Neos... (Filed With SEC on October 3, 2019)

Fourth Amendment to the Facility Agreement, dated as of October 2, 2019, by and between Deerfield Private Design Fund III, L.P., Deerfield Special Situations Fund, L.P. and... (Filed With SEC on October 3, 2019)

Neos Therapeutics, Inc. Non-Employee Director Compensation Policy dated June 13, 2019 (Filed With SEC on June 18, 2019)

Third Amendment to Facility Agreement dated as of March 26, 2019 by and among the Registrant, Deerfield Private Design Fund III, L.P., and Deerfield Special Situations Fund, L.P (Filed With SEC on May 10, 2019)

Employment Agreement dated March 18, 2019, by and between the Registrant and John Limongelli (Filed With SEC on May 10, 2019)

Settlement Agreement, by and between the Registrant and Teva Pharmaceuticals USA, Inc., dated as of December 21, 2018 (Filed With SEC on March 18, 2019)

Underwriting Agreement, dated November 6, 2018, between Neos Therapeutics, Inc. and Cantor Fitzgerald & Co (Filed With SEC on November 6, 2018)

Form of Senior Secured Convertible Promissory Note (Filed With SEC on November 5, 2018)

Second Amendment to Facility Agreement, dated as of November 5, 2018, by and among Neos Therapeutics, Inc., Deerfield Private Design Fund III, L.P. and Deerfield Special Situation... (Filed With SEC on November 5, 2018)

Registration Rights Agreement, dated as of November 5, 2018, by and among Neos Therapeutics, Inc., Deerfield Private Design Fund III, L.P. and Deerfield Special Situation Fund, L.P (Filed With SEC on November 5, 2018)

Exclusive License Agreement, dated as of October 23, 2018, by and between Neos Therapeutics, Inc. and NeuRx Pharmaceuticals LLC (Filed With SEC on October 24, 2018)

Separation Agreement, dated June 27, 2018, by and between the Company and Vipin Garg (Filed With SEC on June 27, 2018)

Employment Agreement, dated June 27, 2018, by and between the Company and Gerald McLaughlin (Filed With SEC on June 27, 2018)

Settlement Agreement, by and between the Registrant and Actavis Laboratoris FL, Inc., dated as of October 17, 2017 (Filed With SEC on March 16, 2018)

NEOS THERAPEUTICS, INC. 4,800,000 Shares of Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENT June 26, 2017 (Filed With SEC on June 29, 2017)

SENIOR SECURED CONVERTIBLE NOTE (Filed With SEC on June 5, 2017)

FIRST AMENDMENT TO FACILITY AGREEMENT (Filed With SEC on June 5, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 5, 2017)

LICENSE AGREEMENT BY AND AMONG NEOS THERAPEUTICS, INC. AND SHIRE LLC DATED AS OF MARCH 6, 2017 (Filed With SEC on May 10, 2017)

NEOS THERAPEUTICS, INC. 5,000,000 Shares Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on February 3, 2017)

FACILITY AGREEMENT (Filed With SEC on August 12, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on May 31, 2016)

NEOS THERAPEUTICS, INC. AMENDMENT AND WAIVER (Filed With SEC on March 18, 2016)

NEOS THERAPEUTICS, INC. SENIOR EXECUTIVE CASH INCENTIVE BONUS PLAN (Filed With SEC on November 13, 2015)

NEOS THERAPEUTICS, INC. [ ] Shares Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on July 13, 2015)

NEOS THERAPEUTICS, INC. 2015 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on July 13, 2015)

INDEMNIFICATION AGREEMENT (Filed With SEC on July 13, 2015)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on July 13, 2015)

SUPPLY AGREEMENT (Filed With SEC on June 26, 2015)

NEOS THERAPEUTICS, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on June 19, 2015)

WARRANT AGREEMENT NEOS THERAPEUTICS, INC. (Filed With SEC on June 19, 2015)

NEOS THERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT June 9, 2015 (Filed With SEC on June 19, 2015)

NEOS THERAPEUTICS, INC. 2009 EQUITY PLAN (Filed With SEC on June 19, 2015)

NEOS THERAPEUTICS, INC. 2009 EQUITY PLAN EMPLOYEE NON-QUALIFIED STOCK OPTION AWARD AGREEMENT (Filed With SEC on June 19, 2015)

NEOS THERAPEUTICS, INC. THIRD AMENDED AND RESTATED SUBORDINATED PROMISSORY NOTE (Filed With SEC on June 19, 2015)

Category

Industry

Companies

Contracts

Neos Therapeutics, Inc. Contracts & Agreements